|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02327 MEILLEUREHEALTH
Nominal 
0.280 +0.005 (+1.818%) | 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Turnover | 17,453 | -41.887% | 50,676 | 129,304 | 119,894 | 253,031 |
| Cost of Sales | (3,292) | -77.514% | (21,771) | (51,214) | (53,133) | (152,102) |
| Gross Profit | 14,161 | -8.004% | 28,905 | 78,090 | 66,761 | 100,929 |
| 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | 23,813 | 20,086 | 13,581 | 15,190 | |
| Change in FV & Impairment on Others | (461) | -- | (20,224) | (3,962) | -- | -- | |
| Profit / (Loss) on Disposal | (127) | -- | -- | 3,900 | 9,435 | 14,844 | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (1,089) | -36.686% | (3,016) | (4,353) | (14,774) | (11,068) | |
| Profit / (Loss) before Taxation | 15,907 | 98.218% | 45,401 | 52,983 | 25,385 | 85,704 | |
| Taxation | (763) | -- | (13,356) | (14,493) | (7,605) | (25,248) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 13 | -94.468% | 435 | 2,340 | 42 | (133) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 15,157 | 79.055% | 32,480 | 40,830 | 17,822 | 60,323 | |
| 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Net Finance Costs / (Income) | (10,025) | 259.964% | (11,751) | (7,416) | (15,460) | (4,064) |
| Depreciation & Amortisation | -- | -- | 1,631 | 2,639 | 3,852 | 3,576 |
| Directors' Emoluments | -- | -- | 2,585 | 1,693 | 2,614 | 3,938 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 0.370 | 76.190% | 0.790 | 1.000 | 0.430 | 1.420 |
| DPS (cts) | 0.150 | -- | 0.400 | 0.400 | 1.600 | 0.000 |
| Dividend Payout Ratio (%) | 40.541% | -- | 50.633% | 40.000% | 372.093% | -- |
| Cash flow per share ($) | -- | -- | 0.045 | (0.033) | 0.011 | (0.020) |
| NBV per share ($) | 0.298 | -- | 0.294 | 0.306 | 0.323 | 0.339 |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 15,157 |
| %Change | 79.055% |
| EPS / (LPS) | HKD 0.004 |
| NBV Per Share ($) | HKD 0.298 |